Exclusive

Publication

Byline

Singapore Clinical Trial: A randomized, placebo-controlled, participant- and investigator-blinded study to evaluate the efficacy in reducing atrial fibrillation burden (AFB) as well as the safety, tolerability, and pharmacokinetics of oral PKN605 in participants with atrial fibrillation

Singapore, April 22 -- The Health Sciences Authority received information related to the study titled 'A randomized, placebo-controlled, participant- and investigator-blinded study to evaluate the eff... Read More


Singapore Clinical Trial: A Phase 2/3 Randomized Study to Evaluate the Safety, Efficacy, and Optimal Dose of Telisotuzumab Adizutecan in Combination with Osimertinib as First-Line Treatment in Patients with Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer

Singapore, April 22 -- The Health Sciences Authority received information related to the study titled 'A Phase 2/3 Randomized Study to Evaluate the Safety, Efficacy, and Optimal Dose of Telisotuzumab ... Read More


Singapore Clinical Trial: A Study to Evaluate the Effect of Fasting Duration and Temporary Withholding of Tirzepatide on Retained Gastric Contents Using Gastric Ultrasound in Participants with Type 2 Diabetes Mellitus and Participants with Overweight or Obesity without Type 2 Diabetes Mellitus.

Singapore, April 22 -- The Health Sciences Authority received information related to the study titled 'A Study to Evaluate the Effect of Fasting Duration and Temporary Withholding of Tirzepatide on Re... Read More


Singapore Clinical Trial: A Phase 1/2 Open-Label, Umbrella Platform Design Study of Investigational Agents in Combination With Pembrolizumab (MK-3475) With or Without Chemotherapy in Participants With 1L Locally Advanced Unresectable/Metastatic Esophageal Cancer: KEYMAKER-U06 Substudy 06E

Singapore, April 22 -- The Health Sciences Authority received information related to the study titled 'A Phase 1/2 Open-Label, Umbrella Platform Design Study of Investigational Agents in Combination W... Read More


Clinical Trial: Pharmacogenetics and Model-Informed Optimisation of Hydroxyurea

U.S., April 22 -- ClinicalTrials.gov registry received information related to the study (NCT07543289) titled 'Pharmacogenetics and Model-Informed Optimisation of Hydroxyurea' on April 15. Brief Summa... Read More


Clinical Trial: RATS Sleeve Lobectomy After Neo-Chemo-IO for NSCLC

U.S., April 22 -- ClinicalTrials.gov registry received information related to the study (NCT07541521) titled 'RATS Sleeve Lobectomy After Neo-Chemo-IO for NSCLC' on April 08. Brief Summary: The goal ... Read More


Clinical Trial: Transgender Analysis of Nephrological Studies Focused on Renal Metrics

U.S., April 22 -- ClinicalTrials.gov registry received information related to the study (NCT07542964) titled 'Transgender Analysis of Nephrological Studies Focused on Renal Metrics' on April 10. Brie... Read More


Clinical Trial: Complementary and Alternative Medicine Among Patients With Hematologic Malignancies in France

U.S., April 22 -- ClinicalTrials.gov registry received information related to the study (NCT07541326) titled 'Complementary and Alternative Medicine Among Patients With Hematologic Malignancies in Fra... Read More


Clinical Trial: Aspirin 50 mg vs. 100 mg in Elderly Cardiovascular Disease Patients

U.S., April 22 -- ClinicalTrials.gov registry received information related to the study (NCT07542860) titled 'Aspirin 50 mg vs. 100 mg in Elderly Cardiovascular Disease Patients' on April 14. Brief S... Read More


Clinical Trial: Nanochon Chondrograft First in Human (FIH) Early Feasibility Study (EFS) - Panama

U.S., April 22 -- ClinicalTrials.gov registry received information related to the study (NCT07542184) titled 'Nanochon Chondrograft First in Human (FIH) Early Feasibility Study (EFS) - Panama' on Apri... Read More